Showing results (331-340 of 2,547) with videos related to
Sort By:
Pageof 255
American Journal of Therapeutics|May 1, 1996
Single- and Multiple-Dose Pharmacokinetics of Reduced Metabolite (MDL 74,156) following Oral Administration of Dolasetron Mesylate to Normal Male SubjectsAjit Shah, Robert Lanman, Vijay Bhargava, et al.American Journal of Therapeutics|May 1, 1996
Metoclopramide-Induced Vascular Hyperreactivity: A Comparative Study Between Normotensive and Hypertensive SubjectsMario Blanco, Ingrid Jelambi, Northan Hurtado, et al.American Journal of Therapeutics|July 1, 1996
Influence of HOE 140, A Bradykinin Receptor Antagonist, in the Isolated Mesenteric Vascular Bed of the RatDonald E. Smith, Alan D. Kaye, Bin Kang, et al.American Journal of Therapeutics|July 1, 1996
Effects of Isradipine on 24-h Blood Pressure, Left Ventricular Hypertrophy and Hemodynamics in Type II Diabetic Hypertensive PatientsL. A. Ferrara, R. Iannuzzi, I. Gaeta, et al.American Journal of Therapeutics|July 1, 1996
Anaphylaxis and Anaphylactoid Reactions: Diagnosis and ManagementAllan T. Luskin, Susan S. LuskinAmerican Journal of Therapeutics|July 1, 1996
Clinical Trials: Design Flaws Associated with Use of a PlaceboTon J.M. CleophasAmerican Journal of Therapeutics|August 1, 1996
Bioequivalence Comparison of Two Drug-in-Adhesive Transdermal Nitroglycerin PatchesLester I. Harrison, Dianna J. Riedel, Jane H. Machacek, et al.American Journal of Therapeutics|September 1, 1996
Effects of Terazosin on Glycemic Control, Cholesterol, and Microalbuminuria in Patients with Non--Insulin-Dependent Diabetes Mellitus and HypertensionJ. K. Kirk, J. C. Konen, Z. Shihabi, et al.American Journal of Therapeutics|September 1, 1996
A New Look At United States Drug Development and Approval TimesJoseph A. DiMasiAmerican Journal of Therapeutics|December 20, 2007
Morbidity and mortality among patients with hip fractures surgically repaired within and after 48 hoursPadmini Sircar, Darshan Godkar, Shmuel Mahgerefteh, et al.Pageof 255